US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIMPLIFY PROPEL OPPORTUNITIES ETF

17.05

-0.0336-0.20%

Volume:395

Turnover:6.77K

Market Cap:73.83M

PE:- -

High:17.05

Open:17.05

Low:17.05

Close:17.08

52wk High:21.31

52wk Low:14.90

Shares:4.33M

Float Shares:4.33M

Volume Ratio:0.02

T/O Rate:0.01%

Dividend:2.72

Dividend Rate:15.95%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

BofA Securities Boosts Targets on Chinese CXO Players as Strong Biotech Funding Fuels R&D

Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/SURI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SURI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SURI\",,,,,undefined,":{"symbol":"SURI","market":"US","secType":"STK","nameCN":"SIMPLIFY PROPEL OPPORTUNITIES ETF","latestPrice":17.05,"timestamp":1791574103144,"preClose":17.0836,"halted":0,"volume":395,"delay":0,"changeRate":-0.0019667985670467495,"floatShares":4330001,"shares":4330001,"eps":0,"marketStatus":"Trading","change":-0.0336,"latestTime":"10-09 15:32:18 EDT","open":17.05,"high":17.05,"low":17.05,"amount":6765.23373,"amplitude":0,"askPrice":17.48,"askSize":100,"bidPrice":16.94,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":17.0836,"sharesOutstanding":4520001,"nav":17.0092,"aum":74834944.31,"dividendRate":0.15949,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":17.07,"preClose":17.0836,"latestTime":"19:30 EDT","volume":9,"amount":153.8252,"timestamp":1791502203497,"change":-0.0136,"changeRate":-0.000796,"amplitude":0},"volumeRatio":0.017547},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SURI\",,,,,undefined,":{"symbol":"SURI","floatShares":4330001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.017547,"shares":4330001,"dividePrice":2.7193,"high":17.05,"amplitude":0,"preClose":17.0836,"low":17.05,"week52Low":14.9001,"pbRate":"--","week52High":21.31,"institutionHeld":0,"latestPrice":17.05,"eps":0,"divideRate":0.15949,"volume":395,"delay":0,"ttmEps":0,"open":17.05,"prevYearClose":16.675,"prevWeekClose":17.0557,"prevMonthClose":17.5449,"prevQuarterClose":17.5449,"fiveDayClose":17.0557,"twentyDayClose":19.21,"sixtyDayClose":17.8718},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SURI\",params:#limit:5,,,undefined,":[{"date":"2026-09-25","symbol":"SURI","amount":0.68,"announcedDate":"2026-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-25","defaultRemindTime":1790343000000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-30","payableDate":"2026-09-25","currency":"USD","dateTimestamp":1790308800000,"payDate":"2026-09-30"},{"date":"2026-06-25","symbol":"SURI","amount":0.68,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"SURI","amount":0.68,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-09-25","symbol":"SURI","amount":0.68,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"SURI","amount":0.68,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"SIMPLIFY PROPEL OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SURI\",market:\"US\",,,undefined,":[{"executeDate":"2023-03-27","recordDate":"2023-03-28","paymentDate":"2023-03-31","value":1,"currency":"USD"},{"executeDate":"2023-06-27","recordDate":"2023-06-28","paymentDate":"2023-07-03","value":0.68,"currency":"USD"},{"executeDate":"2023-09-27","recordDate":"2023-09-28","paymentDate":"2023-09-29","value":0.68,"currency":"USD"},{"executeDate":"2023-12-26","recordDate":"2023-12-27","paymentDate":"2023-12-29","value":0.68,"currency":"USD"},{"executeDate":"2024-03-25","recordDate":"2024-03-26","paymentDate":"2024-03-28","value":0.68,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SURI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SURI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","PBPH","PINK","JHMH","TBXU","APXH","LLYX","AZNH","PJP","SYNB","GNMX","GDOC","MNTL","PSCH","IBBQ","BBP","FXH","HYLG","PBE","MEDI","CURE","FTXH","XPH","MEDX","BIB","SURI","BBH","CANC","CNCR","FHLC","IDNA","GNOM","PSIL","IBBJ","MRNY","WDNA","IBRN","GPCR","HRTS","PTH","BME","LFSC","IBB","NVIB","SBIO","MDTX","GSKH","FBT","RSPH","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","MDTX","JDOC","JHMH","HYLG","PINK","SBIO","IBBJ","NVIB","FBT","BME","IBRN","PSCH","SURI","TBXU","GNOM","LLYX","PBPH","MEDX","APXH","IBB","GPCR","MRNY","PJP","SYNB","HRTS","WDNA","CURE","PBE","GDOC","PTH","BBH","GNMX","CNCR","FXH","FHLC","LFSC","AZNH","XPH","LENZ","MNTL","GSKH","FTXH","CANC","MEDI","RSPH","PSIL","BBP","IBBQ","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155684243","title":"BofA Securities Boosts Targets on Chinese CXO Players as Strong Biotech Funding Fuels R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=1155684243","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155684243?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:50","pubTimestamp":1786596641,"startTime":"0","endTime":"0","summary":"BofA Securities has released a report indicating that the Chinese CXO sector is poised to benefit from robust biotech venture capital funding. The bank notes that strong financing in the first half...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","WX","CXO","LU2328871848.SGD","APXH","LU0708995583.HKD","LU2488822045.USD","LU0456842615.SGD","LU1997244956.HKD","FHLC","SMCO","LU1719994722.HKD","LU2045819591.USD","BK1576","LU1251922891.USD","BMED","LU1808992512.USD","LU2242644610.SGD","IE00B5MMRT66.SGD","LFSC","LU0348766576.USD","PSIL","LU2125910500.SGD","XBIX","BK1583","IE00BPRC5H50.USD","LU0320764599.SGD","LU1997245094.SGD","LU1934453819.USD","603259","IDNA","BBC","BK0216","BK1141","LU1770034418.SGD","IBRN","IE00B543WZ88.USD","LU0611395673.USD","LU1046422090.SGD","LU1303224171.USD","LU1969619763.USD","LU1979443071.USD","MEDI","PSCH","SURI","LU0348767384.USD","02359","LU0052750758.USD","LU0700851271.USD","LU1997245177.USD","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111112440","title":"Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=1111112440","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111112440?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:35","pubTimestamp":1786588544,"startTime":"0","endTime":"0","summary":"A report from Bank of America Securities indicates that Chinese CRO/CDMO companies are poised to benefit from robust first-half funding in the global and Chinese biotech sectors, along with active...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456842615.SGD","LU0307460666.USD","BMED","SG9999002562.SGD","LU0128526141.USD","LU1688375341.USD","LU1934453819.USD","PSIL","LU1997244956.HKD","SMCO","LU0359201612.USD","LU0029874061.USD","LU2045819591.USD","LU2039709279.SGD","IBRN","LU2242644610.SGD","LU0700851271.USD","BK1521","LU0856984785.SGD","BK1141","LU0516423174.USD","LU2488822045.USD","LU1969619763.USD","LU0327786744.USD","161027","LU1880383366.USD","LU1770034418.SGD","BK1576","LU1719994722.HKD","02359","LU0588546209.SGD","LU0516422440.USD","XBIX","FHLC","LU0348735423.USD","LU0052750758.USD","LU1242518857.USD","LU1997245177.USD","LU0359202008.SGD","IE00B0JY6N72.USD","LU0140636845.USD","SURI","03759","LU0051755006.USD","LU1303224171.USD","LU2328871848.SGD","LU0039217434.USD","LU0819121731.USD","LU1251922891.USD","LU0823426308.USD","LU0348766576.USD","KURE","LU0516422952.EUR","LU0979878070.USD","PSCH","LU0456827905.SGD","LU0417516738.SGD","APXH","BK1610","LU3063872942.SGD","LU0348767384.USD","02269","BK0216","MEDI","BBC","LU1720050803.USD","LU0043850808.USD","LU0516422366.SGD","IDNA","LU0456846285.SGD","LU0326950275.SGD","CXO","BK1589","BK1583","LU0417516902.SGD","LU2125910500.SGD","LU1794554557.SGD","LU0708995583.HKD","LU0611395673.USD","LFSC","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1046422090.SGD","LU1997245094.SGD","LU2495084118.USD","LU1979443071.USD","SG9999002463.SGD","LU1808992512.USD","LU0320764599.SGD","WX","IE00BPRC5H50.USD","LU0181495838.USD","LU1242518931.SGD","LU0823426480.USD","603259","LU0516423091.SGD","LU0348825331.USD","LU0572944931.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SURI\",params:#limit:6,delay:false,,,undefined,":[]}}